BG105552A - Използване на амтолметин гуацил за лечение на чревни възпаления - Google Patents

Използване на амтолметин гуацил за лечение на чревни възпаления

Info

Publication number
BG105552A
BG105552A BG105552A BG10555201A BG105552A BG 105552 A BG105552 A BG 105552A BG 105552 A BG105552 A BG 105552A BG 10555201 A BG10555201 A BG 10555201A BG 105552 A BG105552 A BG 105552A
Authority
BG
Bulgaria
Prior art keywords
prioduction
inflammatory drugs
amtolmetin guacyl
intestinal inflammations
guacyl
Prior art date
Application number
BG105552A
Other languages
English (en)
Other versions
BG65575B1 (bg
Inventor
Sergio Anzalone
Original Assignee
Medosan Ricerca S.R.L.
Sigma - Tau Industrie Farmaceutiche Riunite S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medosan Ricerca S.R.L., Sigma - Tau Industrie Farmaceutiche Riunite S.P.A. filed Critical Medosan Ricerca S.R.L.
Publication of BG105552A publication Critical patent/BG105552A/bg
Publication of BG65575B1 publication Critical patent/BG65575B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pyrrole Compounds (AREA)

Abstract

Изобретението се отнася до използването на амтолметин гуацил за лечение на чревни възпаления, до приложение на амтолметин гуацил като антитромбозен фактор за лечение на тромбофлебити и за противовъзпалително и обезболяващо лечение, по-специално при пациенти с инфаркт и на хора, страдащи от инсулт от тромботичен тип.
BG105552A 1998-12-03 2001-05-31 Използване на амтолметин гуацил за получаване на противовъзпалителни лекарствени средства за лечение на чревни възпаления BG65575B1 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1998RM000745A IT1302898B1 (it) 1998-12-03 1998-12-03 Uso di amtolmetine guacil per la produzione di farmaci ad effettoantiinfiammatorio nelle infiammazioni intestinali.

Publications (2)

Publication Number Publication Date
BG105552A true BG105552A (bg) 2001-12-29
BG65575B1 BG65575B1 (bg) 2009-01-30

Family

ID=11406239

Family Applications (1)

Application Number Title Priority Date Filing Date
BG105552A BG65575B1 (bg) 1998-12-03 2001-05-31 Използване на амтолметин гуацил за получаване на противовъзпалителни лекарствени средства за лечение на чревни възпаления

Country Status (14)

Country Link
US (1) US6495590B1 (bg)
EP (2) EP1135122B1 (bg)
JP (1) JP2003512293A (bg)
KR (2) KR100660487B1 (bg)
AT (2) ATE433321T1 (bg)
AU (1) AU1680100A (bg)
BG (1) BG65575B1 (bg)
CA (2) CA2353727C (bg)
DE (2) DE69940979D1 (bg)
HU (1) HUP0104491A3 (bg)
IT (1) IT1302898B1 (bg)
PL (2) PL195790B1 (bg)
TR (1) TR200101566T2 (bg)
WO (1) WO2000032188A2 (bg)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1210673B (it) * 1982-02-26 1989-09-20 Medosan Ind Biochimi Antinfiammatoria amidi pirrolacetiche ad attivita'
US6180658B1 (en) * 1995-07-14 2001-01-30 Medosan Ricerca S.R.L. Method for counteracting blood platelet aggregation in a patient in need thereof
IT1278144B1 (it) * 1995-07-14 1997-11-17 Medosan Ricerca Srl Impiego dell'amtolmetineguacil (med 15) come farmaco antisecretivo sulla secrezione gastrica e quindi gastroprotettivo.
US5889041A (en) * 1995-07-14 1999-03-30 Medosan Ricerca S.R.L. Method for treating an inflammatory pathological condition
ITMI962356A1 (it) * 1996-11-13 1998-05-13 Uni Degli Studi Di Brescia D I Uso di composti derivati da molecole ad attivita' antinfiammatoria di tipo non steroideo per la prevenzione e il trattamento di
EP1310250A1 (en) * 1997-08-08 2003-05-14 MEDOSAN RICERCA S.r.l. Use of the compound 2-methoxyphenyl-1-methyl-5P-methylbenzoyl-pyrrol-2-acetamido acetate for the production of an antiinflammatory drug with prevention of gastric hypersecretion and renal impairment
ATE237326T1 (de) 1997-08-08 2003-05-15 Medosan Ricerca Srl Verwendung von 2-methoxyphenyl-1-methyl-5p-methyl-benzoylpyrro -2-acetamido-acetat zur herstellung eines antientzündungsmittels mit vorbeugung von magenhypersekretion und nierenfunktionsstörung

Also Published As

Publication number Publication date
EP1709963A3 (en) 2007-12-26
KR20010108001A (ko) 2001-12-07
CA2353727A1 (en) 2000-06-08
KR100627750B1 (ko) 2006-09-26
PL195790B1 (pl) 2007-10-31
CA2353727C (en) 2009-09-22
ATE433321T1 (de) 2009-06-15
EP1135122A2 (en) 2001-09-26
HUP0104491A3 (en) 2002-12-28
PL201414B1 (pl) 2009-04-30
TR200101566T2 (tr) 2001-10-22
JP2003512293A (ja) 2003-04-02
BG65575B1 (bg) 2009-01-30
US6495590B1 (en) 2002-12-17
EP1135122B1 (en) 2009-06-10
IT1302898B1 (it) 2000-10-10
CA2634658A1 (en) 2000-06-08
KR20060089247A (ko) 2006-08-08
PL348645A1 (en) 2002-06-03
ITRM980745A1 (it) 2000-06-03
WO2000032188A3 (en) 2000-10-26
HUP0104491A2 (hu) 2002-04-29
AU1680100A (en) 2000-06-19
ATE433748T1 (de) 2009-07-15
DE69940979D1 (de) 2009-07-23
ITRM980745A0 (it) 1998-12-03
EP1709963B1 (en) 2009-06-17
EP1709963A2 (en) 2006-10-11
DE69941019D1 (de) 2009-07-30
WO2000032188A2 (en) 2000-06-08
KR100660487B1 (ko) 2006-12-22

Similar Documents

Publication Publication Date Title
MXPA04005376A (es) Composiciones farmaceuticas y sus usos.
UA41879C2 (uk) Засіб для лікування мотонейронових захворювань
YU31801A (sh) Amidi antranilne kiseline i njihova upotreba kao leka
TWI256891B (en) 17alpha-alkyl-17beta-oxy-estratrienes and intermediate products for their production, use of the 17alpha-alkyl-17beta-oxy-estratrienes for the production of pharmaceutical agents as well as pharmaceutical preparations
BG105880A (bg) Съединения полезни като противовъзпалителни средства
TR199901174T2 (xx) Yeni heterosiklilmetil-ikameli pirazol t�revleri.
SE0001899D0 (sv) New compounds
MY133392A (en) Novel substituted pyrazole derivatives
SE9702001D0 (sv) Novel compounds
AU5186799A (en) Peptides of il-2 and derivatives thereof and their use as therapeutic agents
AU6682594A (en) Treatment of septic shock
BG104179A (bg) Използване на фанхинон за лечението на болестта на алцхаймер
RS83104A (en) Process to prepare eplerenone
PT1107793E (pt) Conjugados de dextrano-leptina, composicoes farmaceuticas e processos relacionados
HUP0100048A2 (hu) Arilszubsztituált piperazinszármazékok, alkalmazásuk gyógyszerkészítmények előállítására és a vegyületeket tartalmazó gyógyszerkészítmények
ZA979647B (en) Heterocyclic compounds, compositions and uses.
AU3862997A (en) Stable derivatives of ubiquinole, processes for their production and pharmaceutical use thereof
BG105552A (bg) Използване на амтолметин гуацил за лечение на чревни възпаления
IT1318547B1 (it) Impiego dell'aloe-emodin nel trattamento di patologie neoplastiche diorigine neuroectodermica.
IL127143A0 (en) Phospholipid terivatives of non-steroidal anti inflammatory drugs
ZA979645B (en) Heterocyclic compounds, compositions and uses.
ZA979650B (en) Heterocyclic compounds, compositions and uses.
WO1998038994A3 (de) Kombinationspräparat aus 2-methylthiazolidin-2,4-dicarbonsäure und paracetamol
HK1050203A1 (en) Novel fusidic acid derivatives.
AU2002339199A1 (en) Solvates of 3.beta., 28-diacetoxy-18-oxo-19, 20, 21, 29, 30-pentanorlupan-22-oic acid, processes for their preparation and pharmaceutical compositions thereof